Categories
Articles

Accuray launches new TomoHDA and gets FDA okay for CyberKnife M6

… New TomoTherapy System enables faster planning and more focused delivery often resulting in half beam-on time than previously.
… CyberKnife M6 (shown above) is a 3D image-guided and robotically controlled beam and patient positioning radiology de…

… New TomoTherapy System enables faster planning and more focused delivery often resulting in half beam-on time than previously.

CyberKnife M6 (shown above) is a 3D image-guided and robotically controlled beam and patient positioning radiology delivery system.
Accuray stock (ARAY:NASDAQ) is up 64% year-to-date from $2.72 to $6.95.

By Frank Tobe

Frank Tobe is the owner and publisher of The Robot Report After selling his business and retiring from 25+ years as a provider of computer direct marketing and consulting to the Democratic National Committee, major presidential and other campaigns and initiatives, he has energetically pursued a new career in researching and investing in robotics. In 2013 he co-founded Robo-STOX™ LLC (renamed in 2015 to ROBO-Global) and developed a tracking index for the robotics industry: the ROBO-Global™ Robotics & Automation Index.

Frank is a member of Robohub and also a panel member for panel member for Robohub's Robotics by Invitation series.